Lina Manufacturing Limited, the pharmaceutical manufacturing arm of Sunshine Holdings PLC, unveiled its new brand identity – a powerful logo that reflects the company’s evolution, vision, and ...

COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business ...

Kepler Capital analyst Christophe dombu maintained a Buy rating on MaaT Pharma (MAAT – Research Report) on March 27 and set a price target of €16.50. The company’s shares closed yesterday at ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

MSD’s subcutaneous (SC) Keytruda (pembrolizumab ... from kidney cancer to oesophageal cancer, GlobalData’s Pharmaceutical Intelligence Center estimates that the drug’s consistent growth in revenue won ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking as he announced 25% tariffs on cars and car parts imported into the US.

MSD has entered an exclusive licence agreement with Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma) for the investigational oral small molecule lipoprotein(a) [Lp(a)] inhibitor, HRS-5346.

Excluding Greater China, MSD gains rights for developing, manufacturing and commercialising the therapy globally. Credit: Copyright © 2025 Merck & Co., Inc., Rahway ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...